Search results for "Triglyceride"

showing 10 items of 444 documents

Birth weight, cardiometabolic risk factors and effect modification of physical activity in children and adolescents: pooled data from 12 internationa…

2020

Abstract Objectives Low and high birth weight is associated with higher levels of cardiometabolic risk factors and adiposity in children and adolescents, and increases the risk of cardiovascular diseases, obesity, and early mortality later in life. Moderate-to-vigorous physical activity (MVPA) is associated with lower cardiometabolic risk factors and may mitigate the detrimental consequences of high or low birth weight. Thus, we examined whether MVPA modified the associations between birth weight and cardiometabolic risk factors in children and adolescents. Methods We used pooled individual data from 12 cohort- or cross-sectional studies including 9,100 children and adolescents. Birth weigh…

WaistAdolescentEpidemiologyEndocrinology Diabetes and MetabolismBirth weightMedicine (miscellaneous)Blood Pressure610 Medicine & health030209 endocrinology & metabolism03 medical and health sciences0302 clinical medicinemedicineBirth WeightHumans030212 general & internal medicineChildExerciseTriglyceridesAdiposityCardiometabolic riskNutrition and DieteticsNorwaybusiness.industryCholesterol HDLarticleCardiometabolic Risk FactorsPaediatrics2701 Medicine (miscellaneous)10060 Epidemiology Biostatistics and Prevention Institute (EBPI)medicine.diseaseVDP::Medisinske Fag: 700::Idrettsmedisinske fag: 850/692/700/478/174ObesityPeer review2712 Endocrinology Diabetes and MetabolismLow birth weightBlood pressureRisk factorsCohort2916 Nutrition and Dietetics/692/700/1720Waist Circumferencemedicine.symptombusinesshuman activities/692/499Demography
researchProduct

Etude du rôle du récepteur nucléaire CAR, Constitutive Androstane Receptor, dans le métabolisme des lipides et la susceptibilité à l'athérosclérose

2011

The Constitutive Androstane Receptor (CAR) belongs to the subfamily of nuclear receptors NR1. Initially described as an orphan receptor, CAR is activated by a large number of exogenous molecules and acts as a xenosensor. The activation of CAR by these ligands stimulates transcription of phase I, II and III enzymes required for the detoxification and elimination of xenobiotics. Furthermore CAR is also involved in the metabolism of endogenous molecules such as bile acids, bilirubin or thyroid hormones. CAR has recently been the subject of numerous independent studies that have highlighted his involvement in major metabolic pathways including gluconeogenesis, lipogenesis and lipoprotein metabo…

[SDV.SA]Life Sciences [q-bio]/Agricultural sciencesAthérosclérose[SDV.SA] Life Sciences [q-bio]/Agricultural sciences5[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyVLDL récepteur3’AtherosclerosisAcides biliaires5'-Tetrachloro-1Bile acids4-bis(pyridyloxy)benzene)(35’-Tétrachloro-1[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologyCAR (Constitutive Androstane Receptor)3'TCPOBOP (3TriglycéridesVLDL receptor[ SDV.SA ] Life Sciences [q-bio]/Agricultural sciences[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyTriglycerides
researchProduct

Développement de méthodes de référence pour les biomarqueurs du bilan lipidique : application au contrôle qualité en biologie clinique

2013

Reliable measurements in medical biology are essential for early screening and appropriate follow-up of patients. Ensuring metrological traceability of clinical measurements to higher order reference methods or certified reference materials enables to obtain comparable results over time and between different laboratories that could use different methods to quantify the same biomarker.In this study, reference methods were developed and validated for lipid profile biomarkers (total cholesterol, triglycerides, HDL-C, and LDL-C). Their value added in proficiency testing schemes was demonstrated against consensus mean. They were also used to characterize a certified reference material (CRM) that…

[SDV.SA]Life Sciences [q-bio]/Agricultural sciencesMetrological traceability[SDV.SA] Life Sciences [q-bio]/Agricultural sciencesMass spectrometryCommutabilityProficiency testing schemesSpectrométrie de masseLaboratoires de biologie médicaleMéthodes de référenceClinical LaboratoriesCholesterolReference methodsCholestérolCommutabilitéCertified Reference MaterialsTraçabilité métrologiqueEvaluation externe de la qualitéTriglycéridesMatériaux de Référence Certifiés[ SDV.SA ] Life Sciences [q-bio]/Agricultural sciencesTriglycerides
researchProduct

Postprandial adaptation of intestinal lipid metabolism : role of CD36 and PPAR beta

2011

Postprandial hypertriglyceridemia is an emerging risk factor for cardiovascular diseases and is associated with metabolic syndrome, obesity and insulin resistance. The small intestine participates in the postprandial triglyceridemia since both the size and number of secreted chylomicrons modulate lipoprotein lipase activity (LPL). Chylomicron synthesis is a complex mechanism in which the lipidation of Apolipoprotein B48 (ApoB48) by the Microsomal Triglyceride Transfer Protein (MTP) and the transfer between reticulum and Golgi in which the Liver Fatty Acid Binding Protein (L -FABP) is involved are limiting steps. An intestinal fat-mediated adaptation in postprandial period has been demonstra…

[SDV.SA]Life Sciences [q-bio]/Agricultural sciences[SDV.SA] Life Sciences [q-bio]/Agricultural sciences[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyTriglycéridémie postprandialedigestive oral and skin physiologyPostprandial triglyceridemiaRécepteurPPAR betaPPAR béta[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologyChylomicronslipids (amino acids peptides and proteins)CD36[ SDV.SA ] Life Sciences [q-bio]/Agricultural sciences[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyReceptor
researchProduct

Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an "FCS score".

2018

Familial chylomicronaemia syndrome (FCS) is a rare, inherited disorder characterised by impaired clearance of triglyceride (TG)-rich lipoproteins from plasma, leading to severe hypertriglyceridaemia (HTG) and a markedly increased risk of acute pancreatitis. It is due to the lack of lipoprotein lipase (LPL) function, resulting from recessive loss of function mutations in the genes coding LPL or its modulators. A large overlap in the phenotype between FCS and multifactorial chylomicronaemia syndrome (MCS) contributes to the inconsistency in how patients are diagnosed and managed worldwide, whereas the incidence of acute hypertriglyceridaemic pancreatitis is more frequent in FCS. A panel of Eu…

[SDV]Life Sciences [q-bio]Diagnosis toolpopulation030204 cardiovascular system & hematologyburdenapoa50302 clinical medicineLoss of Function MutationRisk FactorsChylomicrons030212 general & internal medicineAge of OnsetHypolipidemic AgentsBIOMEDICINA I ZDRAVSTVO. Kliničke medicinske znanosti. Interna medicina.Lipoprotein lipaseplasma triglycerideshyperlipoproteinemiaPrognosis3. Good healthUp-RegulationPhenotypeAcute pancreatitislipids (amino acids peptides and proteins)Hyperlipoproteinemia Type IAcute pancreatitis ; Familial chylomicronaemia syndrome ; Major hypertriglyceridaemia ; Multifactorial chylomicronaemiaCardiology and Cardiovascular MedicineFamilial chylomicronaemia syndromeAlgorithmsacute-pancreatitismedicine.medical_specialtyConsensushypertriglyceridemiaetiologyAcute pancreatitis; Familial chylomicronaemia syndrome; Major hypertriglyceridaemia; Multifactorial chylomicronaemia/Decision Support TechniquesDiagnosis Differential03 medical and health sciencesAcute pancreatitis; Familial chylomicronaemia syndrome; Major hypertriglyceridaemia; Multifactorial chylomicronaemia; Cardiology and Cardiovascular MedicinePredictive Value of TestsInternal medicinemedicineHumansGenetic Predisposition to DiseaseAcute pancreatitiBIOMEDICINE AND HEALTHCARE. Clinical Medical Sciences. Internal Medicine.GenotypingTriglyceridesPregnancyReceiver operating characteristicbusiness.industrysevereMultifactorial chylomicronaemiaReproducibility of Resultsmutationslipoprotein-lipase genemedicine.diseaseConfidence intervalAcute pancreatitisLipoprotein LipasePancreatitisCardiovascular System & CardiologyPancreatitisMajor hypertriglyceridaemiabusinessBiomarkersAtherosclerosis
researchProduct

Birth weight, adult weight, and cardiovascular biomarkers : Evidence from the Cardiovascular Young Finns Study

2021

This study quantifies the causal effect of birth weight on cardiovascular biomarkers in adulthood using the Cardiovascular Risk in Young Finns Study (YFS). We apply a multivariable Mendelian randomization (MVMR) method that provides a novel approach to improve inference in causal analysis based on a mediation framework. The results show that birth weight is linked to triglyceride levels (β = −0.294; 95% CI [−0.591, 0.003]) but not to low-density lipoprotein (LDL) cholesterol levels (β = 0.007; 95% CI [−0.168, 0.183]). The total effect of birth weight on triglyceride levels is partly offset by a mediation pathway linking birth weight to adult BMI (β = 0.111; 95% CI [−0.013, 0.234]). The nega…

adult BMIbirth weighttriglyseriditbiomarkkerit3121 Internal medicine3142 Public health care science environmental and occupational healthmonimuuttujamenetelmätLDL cholesterolkausaliteettisydän- ja verisuonitauditsyntymäpainomultivariable Mendelian randomizationLDL-kolesteroli3111 Biomedicinepainoindeksigeneettiset tekijättriglyceridescausal mediation
researchProduct

The pathophysiology of intestinal lipoprotein production

2015

Intestinal lipoprotein production is a multistep process, essential for the absorption of dietary fats and fat-soluble vitamins. Chylomicron assembly begins in the endoplasmic reticulum with the formation of primordial, phospholipids-rich particles that are then transported to the Golgi for secretion. Several classes of transporters play a role in the selective uptake and/or export of lipids through the villus enterocytes. Once secreted in the lymph stream, triglyceride-rich lipoproteins (TRLs) are metabolized by Lipoprotein lipase (LPL), which catalyzes the hydrolysis of triacylglycerols of very low density lipoproteins (VLDLs) and chylomicrons, thereby delivering free fatty acids to vario…

assemblyVery low-density lipoproteinSettore MED/09 - Medicina InternaPhysiologyBlood lipidsReviewBiologyTriglyceride-rich lipoproteininherited disorderslcsh:Physiologysymbols.namesakePhysiology (medical)Lipoprotein lipaselcsh:QP1-981Endoplasmic reticulumdigestive oral and skin physiologytrygliceride-rich lipoproteinschylomicronAssembly; Chylomicron; Inherited disorders; Secretion; Triglyceride-rich lipoproteins; Physiology; Physiology (medical)Golgi apparatussecretionChylomicron assemblyBiochemistrytriglyceride-rich lipoproteinssymbolslipids (amino acids peptides and proteins)LipoproteinChylomicronInherited disorder
researchProduct

Novel anti-obesity drugs and plasma lipids

2014

Obesity is a health problem of global, epidemic proportions and a major risk factor for chronic diseases resulting in accelerated morbidity and mortality. Dyslipidemia with a predominance of small dense LDL, impaired functionality of HDL particles, and increased serum levels of remnant particles due to impaired clearance of triglyceriderich lipoproteins significantly heightens cardiovascular events in obese subjects. Pharmacotherapy in combination with lifestyle modification is the primary approach to reduce obesity-related cardiovascular risk. Although there are several potential anti-obesity drugs, orlistat is the only agent that remains available in the market. Lorcaserin and Qsymia ® , …

business.industryEndocrinology Diabetes and MetabolismTherapeutic effectPharmacologymedicine.diseaseObesityanti-obesity drugs contrave dyslipidemia lorcaserin low-density lipoprotein obesity Qsymia® triglycerideLorcaserinOrlistatPharmacotherapymedicineRisk factorCardiology and Cardiovascular MedicineAdverse effectbusinessDyslipidemiamedicine.drug
researchProduct

Effects of n-3 Polyunsaturated Fatty Acids (ω-3) Supplementation on Some Cardiovascular Risk Factors with a Ketogenic Mediterranean Diet

2015

Background: the ketogenic diet (KD) has become a widely used nutritional approach for weight loss. Some of the KD’s positive effects on metabolism and cardiovascular risk factors are similar to those seen after n-3 polyunsaturated fatty acids (ω-3) supplementation. We hypothesized that a ketogenic Mediterranean diet with phytoextracts combined with ω-3 supplementation may have increased positive effects on cardiovascular risk factors and inflammation. Methods: We analyzed 34 male overweight subjects

cardiovascular risk factorsBlood GlucoseMaleMediterranean dietinflammatory cytokinesmedicine.medical_treatmentN-3 polyunsaturated fatty acidPharmaceutical ScienceOverweightDiet Mediterraneanchemistry.chemical_compoundRisk FactorsWeight lossDrug DiscoveryInsulinlcsh:QH301-705.5Pharmacology Toxicology and Pharmaceutics (miscellaneous)Adipositychemistry.chemical_classificationCardiovascular risk factors; Inflammatory cytokines; Ketogenic diet; N-3 polyunsaturated fatty acids; Omega-3; Weight loss; Drug Discovery3003 Pharmaceutical ScienceMiddle Agedn-3 polyunsaturated fatty acidsketogenic dietCardiovascular DiseasesCytokinesomega-3medicine.symptomDiet KetogenicPolyunsaturated fatty acidAdultmedicine.medical_specialtyInflammatory cytokineBiologyCardiovascular risk factorWeight loArticleInternal medicineFatty Acids Omega-3Weight LossmedicineHumansTriglyceridesAgedAdiponectinPlant ExtractsCholesterolDrug Discovery3003 Pharmaceutical Science<i>n</i>-3 polyunsaturated fatty acidsCholesterol LDLOverweightEndocrinologylcsh:Biology (General)chemistryDietary SupplementsUric acidKetogenic dietMarine Drugs
researchProduct

Renal function is impaired in normotensive chronic HCV patients: role of insulin resistance.

2015

Renal dysfunction is an independent predictor for cardiovascular morbidity and mortality. We investigated whether chronic hepatitis C virus (HCV) infection and the related insulin resistance/hyperinsulinemia influence renal function in comparison with a group of healthy subjects and with another group with metabolic syndrome. We enrolled 130 newly diagnosed HCV outpatients matched for age and gender with 130 patients with metabolic syndrome and 130 healthy subjects. Renal function was evaluated by calculation of glomerular filtration rate (e-GFR, mL/min/1.73 m2) using the CKD-EPI equation. The following laboratory parameters were measured: fasting plasma glucose and insulin, total, LDL- and…

cardiovascular riskMalemedicine.medical_specialtySettore MED/09 - Medicina Internamedicine.medical_treatmentRenal function030204 cardiovascular system & hematologyurologic and male genital diseasesKidney Function Testschronic C hepatitis03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInsulin resistanceChronic C hepatitis Renal function Insulin resistance Cardiovascular risk Metabolic syndromeInternal medicineInternal MedicinemedicineHyperinsulinemiaHumansMetabolic SyndromeCreatinineTriglyceridebusiness.industryInsulinrenal functionCase-control studyHepatitis C ChronicMiddle Agedmedicine.diseaseEndocrinologychemistryCase-Control Studieschronic C hepatitis; renal function; insulin resistance; cardiovascular risk; metabolic syndromeEmergency Medicine030211 gastroenterology & hepatologyFemaleMetabolic syndromeInsulin ResistancebusinessBiomarkersGlomerular Filtration RateInternal and emergency medicine
researchProduct